These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34768908)

  • 1. Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy.
    Aamir R; Fyffe C; Korin N; Lawrence DA; Su EJ; Kanapathipillai M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmin (Human) Administration in Acute Middle Cerebral Artery Ischemic Stroke: Phase 1/2a, Open-Label, Dose-Escalation, Safety Study.
    Mitchell PJ; Yan B; Brozman M; Ribo M; Marder V; Courtney KL; Saver JL;
    J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):308-320. PubMed ID: 27793534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased brain plasmin levels following experimental ischemic stroke in male mice.
    Mindel E; Weiss R; Bushi D; Gera O; Orion D; Chapman J; Shavit-Stein E
    J Neurosci Res; 2021 Mar; 99(3):966-976. PubMed ID: 33296953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered microparticles and nanoparticles for fibrinolysis.
    Disharoon D; Marr DWM; Neeves KB
    J Thromb Haemost; 2019 Dec; 17(12):2004-2015. PubMed ID: 31529593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmin-loaded echogenic liposomes for ultrasound-mediated thrombolysis.
    Kandadai MA; Meunier JM; Hart K; Holland CK; Shaw GJ
    Transl Stroke Res; 2015 Feb; 6(1):78-87. PubMed ID: 25411015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis with plasmin: implications for stroke treatment.
    Marder VJ; Jahan R; Gruber T; Goyal A; Arora V
    Stroke; 2010 Oct; 41(10 Suppl):S45-9. PubMed ID: 20876504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of plasmin in the setting of concomitant aspirin and heparin administration in an animal model of bleeding.
    Sadeghi S; Marder VJ; Stewart D; Kong M; Humphries J; Baumbach GA; Jesmok G
    J Thromb Haemost; 2003 Dec; 1(12):2621-5. PubMed ID: 14675099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombolytic agents].
    Nagao T
    Nihon Rinsho; 2014 Jul; 72(7):1254-7. PubMed ID: 25163317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator.
    Roncal C; Martinez de Lizarrondo S; Salicio A; Chevilley A; Rodriguez JA; Rosell A; Couraud PO; Weksler B; Montaner J; Vivien D; Páramo JA; Orbe J
    Cardiovasc Res; 2017 Aug; 113(10):1219-1229. PubMed ID: 28379489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locally applied recombinant plasmin results in effective thrombolysis in a porcine model of arteriovenous graft thrombosis.
    Hoefer IE; Stroes ES; Pasterkamp G; Levi MM; Reekers JA; Verhagen HJ; Meijers JC; Humphries JE; Rotmans JI
    J Vasc Interv Radiol; 2009 Jul; 20(7):951-8. PubMed ID: 19481472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
    Marder VJ
    Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke.
    Hoda MN; Siddiqui S; Herberg S; Periyasamy-Thandavan S; Bhatia K; Hafez SS; Johnson MH; Hill WD; Ergul A; Fagan SC; Hess DC
    Stroke; 2012 Oct; 43(10):2794-9. PubMed ID: 22910893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of local thrombolytic efficacy of plasmin and rt-PA in an in-vitro flow system; a pilot study.
    Bizjak N; Bajd F; Vidmar J; Blinc A; Marder VJ; Novokhatny V; Serša I
    Blood Coagul Fibrinolysis; 2013 Oct; 24(7):711-4. PubMed ID: 23751605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage.
    Stewart D; Kong M; Novokhatny V; Jesmok G; Marder VJ
    Blood; 2003 Apr; 101(8):3002-7. PubMed ID: 12446443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.
    Ma H; Jiang Z; Xu J; Liu J; Guo ZN
    Drug Deliv; 2021 Dec; 28(1):357-371. PubMed ID: 33517820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
    Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
    Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A targeted ferritin-microplasmin based thrombolytic nanocage selectively dissolves blood clots.
    Seo J; Al-Hilal TA; Jee JG; Kim YL; Kim HJ; Lee BH; Kim S; Kim IS
    Nanomedicine; 2018 Apr; 14(3):633-642. PubMed ID: 29309907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
    Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
    Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?
    Niego B; Medcalf RL
    J Cereb Blood Flow Metab; 2014 Aug; 34(8):1283-96. PubMed ID: 24896566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical studies of plasmin: superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activator.
    Marder VJ
    Thromb Res; 2008; 122 Suppl 3(Suppl 3):S9-S15. PubMed ID: 18722003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.